Stay updated on CABozantinib in NSCLC MET Clinical Trial

Sign up to get notified when there's something new on the CABozantinib in NSCLC MET Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CABozantinib in NSCLC MET Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added the Locations section with new site codes (AV, BA, FI, FO, ME, MI, MO, PA, PD, PG, PI, PR, RE, RM, RO, Torino) and removed individual Location subsections; updated Revision to v3.3.3.
    Difference
    1%
    Check dated 2025-12-22T01:56:39.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added and Revision: v3.3.1 was removed as part of a site version update. This change affects only revision metadata and does not alter any study details, eligibility criteria, or results; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-30T15:55:19.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The page revision label updated from v3.2.0 to v3.3.1; no substantive study content was modified. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-23T14:55:31.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Removed the government funding lapse notice that warned the information may not be up to date and that transactions might be delayed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-16T14:40:24.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The observed updates are minor UI and content formatting changes that do not alter core study details (eligibility criteria, endpoints, or enrollment). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-02T00:52:47.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    Upgraded to version v3.2.0 with a funding-status notice about operational limitations; v3.1.0 was removed. Indicates a maintenance/availability update rather than new content.
    Difference
    4%
    Check dated 2025-10-04T12:28:35.000Z thumbnail image

Stay in the know with updates to CABozantinib in NSCLC MET Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CABozantinib in NSCLC MET Clinical Trial page.